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Abstract
Cardiac magnetic resonance (CMR) is considered a primary
tool for the diagnosis of acute myocarditis, due to its unique
potential for non-invasive identification of the various hall-
marks of the inflammatory response, with relevant impact on
patient management and prognosis. Nonetheless, a marked
variation in sensitivity and negative predictive value has
been reported in the literature, reflecting the intrinsic draw-
backs of current diagnostic criteria, which are based mainly
on the use of conventional CMR pulse sequences. As a
consequence, a negative exam cannot reliably exclude the
diagnosis, especially in patients who do not present an
infarct-like onset of disease. The introduction of new-
generation mapping techniques further widened CMR poten-
tials, allowing quantification of tissue changes and opening
new avenues for non-invasive workup of patients with in-
flammatory myocardial disease.
Main messages
• CMR sensitivity varies in AM, reflecting its clinical polymor-
phism and the intrinsic drawbacks of LLc.
• Semiquantitative approaches such as EGEr or T2 ratio have
limited accuracy in diffuse disease forms.
• T1 mapping allows objective quantification of inflammation,
with no need to normalize measurements.
• A revised protocol including T2-STIR, T1 mapping and LGE
could be hypothesized to improve sensitivity.
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ARVD/C Arrhythmogenic right ventricular
dysplasia/cardiomyopathy
ceSSFP Contrast-enhanced steady-state free
precession
CMP Cardiomyopathy
CMR Cardiovascular magnetic resonance
ECV Extracellular volume fraction
EDV End-diastolic volume
EGEr Early gadolinium enhancement ratio
EMB Endomyocardial biopsy
Gd-BOPTA Gadolinium benzyloxy-propionic-
tetraacetic acid
Gd-DTPA Gadopentetate dimeglumine
FSE Fast spin echo
HHV6 Human herpesvirus 6
IR-GRE Inversion recovery gradient echo
IR-SSFP Inversion recovery steady-state free
precession
LGE Late gadolinium enhancement
LLc Lake Louise criteria
LV Left ventricle
NT-pro
BNP
N-terminal of the prohormone
brain natriuretic peptide
PVB19 Parvovirus B 19
PSIR Phase-sensitive inversion recovery
ROI Region of interest
SCD Sudden cardiac death
SSFP Steady-state free precession
TSE Turbo spin echo
TT-CMP Takotsubo cardiomyopathy
T2p-SSFP T2-prepared steady-state free precession
T2w-STIR Short-tau inversion recovery
prepared fast spin echo
Introduction
Acute myocarditis (AM) is a Bmultifaceted disease^ charac-
terized by a large variety of acute manifestations, potentially
followed by unpredictable sequelae ranging from dilated car-
diomyopathy to recurrent arrhythmias [1, 2]. Although rela-
tively common in clinical practice [2, 3], AM is
underdiagnosed in the community due to the low sensitivity
of conventional diagnostic tools such as ECG, cardiac bio-
markers, and viral serology [1]. The use of endomyocardial
biopsy (EMB) [4] is controversial, given the lack of standard-
ized protocols and the high prevalence of sampling errors
related to the common patchy distribution of myocardial in-
flammation [4, 5].
In this complex scenario, cardiac magnetic resonance
(CMR) was immediately perceived as a potentially
Brevolutionary^ non-invasive tool [6–9], with a unique capacity
to characterize the typical hallmarks of myocardial
inflammation (Fig. 1). Ghelani et al., for example, reported a
retrospective study among a population of 514 patients demon-
strating a fivefold increase (from 5.2 to 28.1%) in the utilization
of CMR inAMover a 10-year period from 2006 to 2015, with a
significant parallel decline in the rate of EMB [10].
Current diagnostic criteria (Lake Louise criteria; LLc) are
based on the application of a recommended standardized pro-
tocol that aims to identify typical signs of the inflammatory
cascade, which consist of oedema, regional hyperemia, and
cellular death [11]. These criteria have been extensively vali-
dated in the literature, and despite suboptimal diagnostic ac-
curacy of about 78 %, are commonly applied in clinical rou-
tine [12, 13]. Promising novel T1/T2 mapping techniques
have recently been introduced that provide quantitative mea-
surements of tissue changes, minimizing subjectivity and er-
rors common in conventional threshold-based post-processing
methods [12–14].
This document analyses lights and shadows of CMR im-
aging in the diagnostic and prognostic assessment of AM and
evaluates the improvement provided by the introduction of
T1/T2 mapping techniques into clinical routine.
Diagnostic criteria in the pre-mapping era: lights
and shadows
The spectrum of currently available sequences for CMR study
of myocarditis is summarized in Table 1.
According to the LLc [11], CMR diagnosis of AM can be
established in the presence of at least two of the following
three features:
a) myocardial oedema detected by T2-weighted techniques;
b) myocardial hyperemia detected by early gadolinium en-
hancement (EGE) techniques;
c) myocardial damage with non-ischemic pattern detected
by late gadolinium enhancement (LGE) techniques.
These three criteria are considered in addition to steady-
state free precession (SSFP) sequences for the assessment of
biventricular volumes and global/regional function (Fig. 2).
1. OEDEMA and INFLAMMATORY INFILTRATION:
Interstitial or intracellular accumulation of water, to-
gether with serological biochemical markers, represents
the most reliable sign of active inflammation [15, 16].
Currently, the most widely used and validated tech-
nique for Boedema-weighted^ imaging is based on the
application of T2-weighted short-tau inversion recovery
sequences (T2w-STIR) [15, 17, 18]. The STIR technique
includes a third 180° inversion pulse integrated into the
classical double-inversion recovery black blood turbo
spin echo (TSE) pulse sequence. The first and second
inversion pulses create a black blood effect; the third
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inversion pulse leads to the suppression of the signal from
fatty tissue and from other stationary tissue with a T1
relaxation time of approximately 200–250 ms. Another
important effect of the third pulse enabling the detection
of oedema is the effect of the inversion of the long T1 on
final signal intensity, so the T1 lengthening related to oe-
dema contributes to the increased signal of oedematous
tissue, together with T2 lengthening [19].
Myocardial oedema in AM often proceeds from a focal
meso- and subepicardial distribution, which is observed in
only about 30 % of patients, to a global pattern of ventric-
ular involvement.
– Current diagnostic criterion:
Definition:
T2w-STIR sequences must be performed using the
same prescription of SSFP images in short-axis
views and in three long-axis planes (two-, three-,
and four-chamber views). However, a body coil is
recommended to avoid signal heterogeneity as com-
pared to SSFP.
The presence of tissue oedema may be detected visu-
ally or, as suggested in the LLc, using a semiquanti-
tative method. Regional oedema is defined as region
of at least 10 adjacent pixels with signal intensitymore
than 2 standard deviations above the mean value of
normal tissue, evident in two orthogonal planes [11].
Diffuse oedema is quantified as the ratio of myocar-
dial to skeletal muscle (T2 ratio) by drawing two
Fig. 1 Freehand drawing schematically representing tissue targets of
CMR in acute myocarditis. A typical inferior-lateral left ventricular
involvement with subepicardial spread is depicted. In most cases, the
process derives from a viral infection that induces myocardial necrosis
(or apoptosis) and triggers an immunoreactive response, with subsequent
vasoactive phenomena and tissue oedema (freehand drawing by Bettina
Conti, MD, Sapienza University of Rome)
Table 1 Information provided by various CMR techniques applied in
the evaluation of acute myocarditis, with main imaging features
CMR
technique
Information provided Imaging features
Cine-SSFP Regional and global
biventricular function,
ventricular mass, and
parietal wall thickness
- Normal or mildly dilated
left or biventricular
cavities
- Ejection fraction
depending on clinical
presentation, usually
mildly depressed
(45–50 %)
- Parietal wall thickness
normal or slightly
increased (>10 mm)
- Pericardial effusion in 30–
50 % of cases
T2w-STIR Increased myocardial free
water content
- Subepicardial or patchy
areas of high signal
intensity following LGE
distribution
- Global hyperintensity
compared to skeletal
muscle (T2 ratio>1.9
according to LLc)
Pre- and
post-Gd
T1w FSE
Myocardial hyperemia and
expansion of
extracellular
compartment
- Sequences frequently
affected by severe
artefacts
- Myocardial hyper-
enhancement compared
to skeletal muscle
(EGEr>4 according to
LLc)
Delayed
enhance-
ment
Myocardial necrosis, scars - No enhancement
- Focal subepicardial
enhancement typically
involving inferolateral
LV wall
- Patchy or longitudinal
striae of mid-wall
enhancement
Native T1
mapping
Pixel-by-pixel assessment
of T1-rt revealing
myocardial changes, first
of all oedema
- T1-rt prolongation:
proposed cut-
off>990 ms (59)
Pre- and
post-Gd
T1
mapping
ECVexpansion due to
enhanced diffusion of
free water and
cardiomyocyte apoptosis
- ECV increase: proposed
cut-off≥27 %; still few
published data (34)
T2 mapping Pixel-by-pixel assessment
of T2-rt revealing
myocardial oedema
- T2-rt prolongation; still
few published data (64)
CMR cardiovascular magnetic resonance, SSFP steady-state free preces-
sion, T2w-STIR T2-weighted short-tau inversion recovery, FSE fast spin
echo,Gd gadolinium, T1-rtT1 relaxation time,ECVextracellular volume,
T2-rt T2 relaxation time, LGE late gadolinium enhancement, LLc Lake
Louise criteria, EGEr early gadolinium enhancement ratio, LV left
ventricle
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distinct regions of interest in the same slice; a ratio ≥
1.9 is considered positive and reflective of global
myocardial oedema [16]. An example of posterolat-
eral left ventricle oedema is showed in Fig. 1.
Limitations:
T2w-STIR images usually allow reliable visual iden-
tification of oedema in patients with a focal pattern of
myocardial involvement, although the limited
contrast-to-noise ratio (CNR) may impede the detec-
tion of subtle tissue changes in a significant minority
of patients.
Other weaknesses may prevent the interpretation of
T2w-STIR images under certain conditions. First,
signal heterogeneity related to coil sensitivity
profiles can produce both false-negative and false-
positive results, and thus the use of reliable surface
coil intensity correction filters or body coils is of
pivotal importance. Second, the dark blood prepara-
tion pulse may introduce regional signal loss in the
LVwall, especially in the posterior and posterolateral
wall, caused by through-plane cardiac motion. Third,
incomplete dark blood preparation may lead to bright
rim blood artefacts along the endocardium, especial-
ly in patients with impaired ventricular function [20].
Another limitation is the qualitative nature of T2w-
STIR images, which implies the need for reference
tissue for interpretation. In the case of suspected dif-
fuse oedema, the reference tissue is the skeletal mus-
cle, although a concomitant signal change within
skeletal muscles, such as that in patients with
coexisting myositis, may adversely affect diagnostic
performance [21, 22].
Finally, a cut-off value of 1.9 was defined using clin-
ical criteria (symptoms, ECG and serologic evidence
of myocardial injury, and angiographic exclusion of
coronary artery disease) as a reference standard for
establishing a diagnosis, without histological valida-
tion [16].
2. HYPEREMIA:
The identification of myocardial hyperemia is the sec-
ond step of the diagnostic workup, according to the LLc.
Endothelial dysfunction and increased vasopermeability
have been considered the pathophysiological mechanisms
for abnormal diffusion of gadolinium from the vascular
compartment to the interstitial space. The tissue hyper-
emia is evaluated with a technique commonly defined as
EGE [11, 16].
– Current diagnostic criterion:
Definition:
The technique used to assess myocardial hyperemia
in the context of LLc was originally proposed by
Abdel-Aty et al. in 2005. A free-breathing black
blood fast spin echo (FSE) T1w sequence with an
acquisition time of 3–4 min is acquired in four iden-
tical axial slices, both before and after (without any
change in the parameters in between) intravascular
injection of 0.1 mmol of gadopentetate dimeglumine
(Gd-DTPA) [11].
Sequence parameters should be adjusted to maxi-
mize T1 weighting; in particular, an echo train length
of less than 4 is desirable. According to LLc, diffuse
hyperemia can be detected by calculating the early
gadolinium enhancement ratio (EGEr): endocardial
and epicardial contours should be traced on both pre-
Fig. 2 Comprehensive CMR evaluation in a 27-year-old man with acute
myocarditis following an upper respiratory infection. At admission,
patient presented with acute chest pain, abnormal ST segment elevation
in the inferolateral leads, and mildly elevated troponin; left ventricular
global function was preserved (a, b; ejection fraction 56 %). Typical
hallmarks of active myocardial inflammation are portrayed, consisting
of meso/subepicardial striae of high signal intensity on both T2-STIR
and LGE images (c–e), combined with a positive EGEr (d; 7.6).
Corresponding native T1 parametric map calculated using a modified
Look-Locker inversion recovery (MOLLI) sequence with a 1.5 T
magnet (MAGNETOM Avanto; Siemens Healthcare, Erlangen,
Germany) shows increased T1 values in the same location (1211±
16 ms; normal reference value mean 1027±61 ms; f)
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and post-contrast images, and a reference region of
interest (ROI) should be placed on the skeletal mus-
cle located within the same slice. The myocardial
enhancement should be normalized on the skeletal
muscle enhancement, and an EGEr ≥ 4 is considered
positive for myocardial inflammation [11].
Limitations:
EGE imaging is generally considered the least robust of
the three components of the LLc, as FSE sequences
originally proposed [11] are limited by inconsistent im-
age quality in many patients [21]. In particular, this
sequence is highly prone to severe respiratory artefacts
caused by free breathing during acquisition.
Second, the acquisition of only 3–4 subsequent slices
limits anatomic coverage of the left ventricle, imped-
ing a panoramic assessment of the myocardial wall.
Third, the cut-off value is validated with one
standard-relaxivity contrast medium (Gd-DTPA)
and may be not acceptable if higher relaxivity agents
are used (e.g., Gd-BOPTA and gadobutrol).
Therefore, a redefinition of thresholds is needed for
agents with higher relaxivity, as has already been
reported in a similar model of breast MRI [23].
Fourth, signal normalization may be hampered by
coexisting skeletal muscles disease. Hence, in pa-
tients with an increase in skeletal muscle signal
intensity ≥ 20 %, as well as in patients with a
recent history of muscular pain, an increase of >
45 % in absolute myocardial signal intensity be-
tween pre- and post-gadolinium images is sug-
gested as a threshold consistent with myocarditis,
rather than normalized EGEr [11].
Table 2 Overview of the diagnostic performance of individual conventional CMR criteria and Lake Louise criteria for myocardial characterization in
AM; articles are listed in chronological order (see specific references in the text)
First author (reference) Year N EGEr T2 ratio LGE 2/3 Positive criteria (LLc) Reference standard
Abdel-Aty [16] 2005 48 Se 80 Se 84 Se 44 Se 76 Clinical/coronary angiography
Spec 68 Spec 74 Spec 100 Spec 95
Acc 74 Acc 79 Acc 71 Acc 85
Röttgen [33] 2011 131 Se 49 Se 58 Se 31 / EMB
Spec 74 Spec 57 Spec 88
Acc 57 Acc 58 Acc 50
Stensaeth [32] 2012 42 Se 31 Se 57 Se 64 Se 76 Clinical/coronary angiography
Spec - Spec - Spec - Spec -
Acc - Acc - Acc - Acc -
Lurz [30] 2012 70 Se 76 Se 64 Se 74 Se 81 EMB
Spe 53 Sp 65 Spec 65 Spec 71
Acc 70 Acc 63 Acc 71 Acc 79
Šramko [36] 2013 42 Se 40 Se 7 Se 87 Se 53 EMB
Spec 96 Spec 100 Spec 44 Spec 93
Acc 76 Acc 66 Acc 60 Acc 78
Chu [13] 2013 45 Se 66 Se 69 Se 77 Se 80 Clinical/coronary angiography
Spec 90 Spec 100 Spec 60 Spec 90
Acc 72 Acc 76 Acc 73 Acc 82
Francone [31] 2014 57 Se 61 Se 47 Se 60 Se 61 EMB
Spec - Spec - Spec - Spec -
Acc - Acc - Acc - Acc -
Radunski [34] 2014 125 Se 63 Se 76 Se 61 Se 84 Clinical/coronary angiography
Spec 71 Spec 42 Spec 100 Spec 57
Acc 59 Acc 70 Acc 67 Acc 79
Luetkens [21] 2014 66 Se 83 Se 79 Se 75 Se 92 Clinical/coronary angiography
Spec 42 Spec 61 Spec 100 Spec 80
Acc 60 Acc 68 Acc 91 Acc 85
Pooled data Se 60 Se 63 Se 59 Se 77
Spec 68 Spec 64 Spec 85 Spec 81
Acc 63 Acc 63 Acc 71 Acc 78
EGEr early gadolinium enhancement ratio = enhancementmyocardium/enhancementskeletal muscle,T2 ratio = signal intensitymyocardium/signal intensityskeletal
muscle, LGE late gadolinium enhancement, LLc Lake Louise criteria, Se sensitivity, Spec specificity, Acc diagnostic accuracy, EMB endomyocardial
biopsy
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An interesting alternative method for fast assessment
of myocardial hyperemia in AMwas recently report-
ed, which relies on SSFP sequences acquired soon
after contrast administration (ceSSFP) [24]. This ap-
proach overcomes most of the drawbacks of original
FSE sequences and seems to be effective for the
identification of areas of regional hyperemia, al-
though it is not yet validated in patients with EMB-
proven AM. However, the ceSSFP technique has not
yet been implemented in the assessment of diffuse
changes involving the entire LV wall, and this is its
main limitation.
3. MYOCYTE DEATH and FIBROSIS
Myocyte necrosis with extracellular space expansion
followed by replacement fibrosis occurs in AM as a con-
sequence of either direct viral cellular damage or cell-
mediated immunological injury. Both tissue changes lead
to an increase in delayed gadolinium accumulation, with
subsequent positive LGE. Typical disease patterns are
characterized by mid-wall or subepicardial LGE distribu-
tion, with patchy or linear areas of high signal intensity
[25]. The inferolateral mid-basal wall and the septum are
the more involved segments [26]. This pattern is clearly
different from the ischemic pattern, the latter character-
ized by subendocardial or transmural LGE, fitting the
segmental distribution of coronary arteries, with possible
associated microvascular obstruction.
Several sequences are available today for the assess-
ment of LGE, including the two-dimensional (2D) and
three-dimensional (3D) inversion recovery gradient echo
sequences (IR-GRE), the 2D and 3D inversion recovery
SSFP sequences (IR-SSFP), and the phase-sensitive in-
version recovery sequences (PSIR-GRE or PSIR-SSFP)
that eliminate the need for a precise null time for normal
myocardium. This sequence uses phase-sensitive detec-
tion to remove the background phase while preserving
the signal of the desired magnetization during IR [27].
Figure 2 (Panel E) shows a typical subepicardial LGE
of the lateral wall.
– Current diagnostic criterion:
Definition:
LGE is considered positive if at least one focal
area of high signal intensity with non-ischemic
pattern of distribution is outlined in at least two
orthogonal planes [11].
Fig. 3 Non-fulminant acute myocarditis in a 44-year-old man presenting
with sudden occurrence of signs and symptoms of heart failure (New
York Heart Association [NYHA] class III). Cine-SSFP four-chamber
end-diastolic frame shows a mildly dilated left ventricular cavity (EDV
187 mL) with significant right-sided pleural effusion; ejection fraction is
mildly depressed (44 %). Typical subepicardial striae of high signal
intensity are located at the level of the mid-inferior left ventricle on
both T2w-STIR (b) and LGE images (c). Native (d) and post-contrast
(e) T1 mapping scans were also performed using a modified Look-Locker
inversion recovery (MOLLI) sequence with a 1.5 T scanner
(MAGNETOM Avanto; Siemens Healthcare, Erlangen, Germany),
showing abnormally elevated extracellular volume within the mid-
inferior segment (36.7 %).
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Suggested LLc protocol recommends the application
of conventional segmented two-dimensional breath-
hold IR-GRE pulse sequence.
Application of a fat-saturation pre-pulse may also be
helpful for discriminating epicardial fat from patho-
logical subepicardial LGE foci.
Any quantitative approach for LGE quantification
was recommended in the LLc, although semi-
automated standard deviat ion (SD)-based
thresholding techniques are commonly used to-
day in different clinical settings, primarily in the
assessment of acute myocardial infarction (AMI)
[28].
Limitations:
LGE has been extensively validated as a robust and
reproducible technique for detecting myocardial fi-
brosis andmyocyte necrosis in patients with AM [26,
29, 30].
However, LGE detection relies on differences in gad-
olinium concentration between pathological and
Bnormal^ segments. Such differences may not exist
if the process is diffuse, or may be insufficient to
create contrast in the presence of mild focal
involvement.
Recent data have demonstrated a limited sensitivity
of the LGE technique, mainly in patients with less
common disease onset such as arrhythmic or
cardiomyopathic presentations [31]. These results,
correlated with histology, better demonstrate that
LGE may be less sensitive for the detection of myo-
carditis with limited or non-focal myocyte injury.
Diagnostic performance of LLc
Clinical studies investigating the diagnostic performance of
LLc [12] in AM were selected and are reported in Table 2
[12, 16, 21, 30–36].
Pooled analysis of results (Table 2) confirmed that LLc
(positivity of 2/3 parameters) are more sensitive than each
single parameter, and are thus able to partially overcome their
diagnostic limitations. Nevertheless, CMR based on LLc
yielded suboptimal results: pooled sensitivity of 77 % and
specificity of 81 %, slightly lower than the specificity provid-
ed by LGE alone (87 %), with diagnostic accuracy of 78 %.
Prognostic value of CMR
The acute presentation of myocarditis is highly variable, rang-
ing from asymptomatic or mildly symptomatic forms to sud-
den cardiac death (SCD). AM has been reported to be respon-
sible for at least 5 % of outpatient SCD [37], and this can
increase to 42 % in the clinical setting among young patients
with AM [38].
The long-term prognosis is usually favorable, but a
significant percentage of patients affected by AM expe-
rience progressive left ventricle dysfunction and dilata-
tion. Prospective studies have suggested that AM causes
at least 10 % of dilated cardiomyopathy [39], and that
post-myocarditis scar may represent the substrate of life-
threatening ventricular arrhythmias. Therefore, the iden-
tification of high-risk patients could have very important
clinical implications.
Mahrholdt and colleagues found that left ventricular
end-diastolic volume (EDV), the presence of LGE in the
interventricular septum, and the total amount of LGE at
initial CMR were the strongest independent predictors
of impaired ventricular function and ventricular dilata-
tion at follow-up in a cohort of patients with parvovirus
B 19 (PVB19) and/or human herpesvirus 6 (HHV6)
infections [40]. Moreover, Grün et al. found that LGE
was the best independent predictor of both all-cause and
cardiac mortality (hazard ratios of 8.4 and 12.8, respec-
tively) in long-term follow-up of 222 consecutive pa-
tients with biopsy-proven viral myocarditis [41].
Another interesting result coming from the same cohort
of patients was that, independently of left ventricular
volumes and function, no patient without LGE experi-
enced SCD [41]. Additionally, Schumm et al. recently
reported that a negative CMR in patients referred for
clinically suspected myocarditis was associated with
good prognosis at follow-up [42].
Fig. 4 Revised diagnostic algorithm for the clinical workup in patients
with clinically suspected acute myocarditis. Routine inclusion of T1
mapping techniques (native and ECV) in the scanning protocol would
enable the coupling of the high specificity of T2-STIR and LGE
techniques with the increased sensitivity of T1-relaxation changes
measurements (particularly in mild focal or diffuse forms of disease).
According to the literature, a combination of functional data and
inflammation/necrosis imaging correlates provided by CMR may serve
as a predictor of functional and clinical recovery at follow-up (see text for
further explanation).
Insights Imaging (2016) 7:99–110 105
Diagnostic role of CMR, based on patient
presentation
The wide and expanding use of CMR in the clinical set-
ting of AM is attributable to its unique capacity to com-
prehensively evaluate the various components of myocar-
dial inflammation cascade.
Significant variations in sensitivity and negative predictive
values have been reported in the scientific literature, reflecting
both the syndromic nature of the disease and the technical
drawbacks of conventional CMR sequences, with evidence
that a negative CMR exam cannot reliably rule out a diagnosis
of AM.
Diagnostic pathways based on the three main clinical sce-
narios of AM can be suggested as evidence of the recent
literature on the diagnostic accuracy and prognostic value of
CMR.
1) Patients presenting with acute chest pain, positive tropo-
nin test results, and typical ST segment abnormalities
In the setting of symptomatic patients, for chest pain
with typical ST elevation, increased troponin, and pre-
served LV function, CMR is pivotal in the diagnosis of
AM.
The first role of CMR is the exclusion of alternative
diagnoses with similar clinical presentations, such as
takotsubo or AMI with non-obstructive coronary artery
disease [43–47].
If the CMR is positive for AM according to LLc, ap-
propriate management needs to be carefully evaluated,
taking into account the clinical course and the CMR re-
sults, particularly the extent, location, and distribution of
LGE [40]. Excellent prognosis is expected in the case of
completely normal CMR [42].
EMB is generally not indicated in this specific clinical
scenario, according to the scientific statement regarding
the role of EMB in the management of cardiovascular
disease published by the American Heart Association
(AHA), the American College of Cardiology (ACC),
and the European Society of Cardiology (ESC) [48].
However, the position statement of the ESC on myocar-
ditis is not in complete agreement on this point [49].
2) Patients with new onset of heart failure syndrome of un-
known etiology [16, 43]
CMR is of value for clarifying the underlying patho-
physiology in patients presenting with new-onset heart
failure (HF) in the absence of chest pain or known prior
myocardial infarction, potentially acting as gatekeeper to
invasive coronary angiography (Fig. 3) [50].
Post-myocarditis forms, however, are not always rec-
ognizable in this specific setting due to a prolonged sub-
acute myocardial inflammation preceding clinical mani-
festations, and leading to progressive water reabsorption
with less evident signal changes [31].
EMB remains the primary alternative for these patients
[51] due to the meaningful impact on subsequent thera-
peutic decisions [49].
3) Patients presenting with sudden occurrence of
palpitations/lipothymia-hypotension related to the pres-
ence of previously unknown ventricular arrhythmias
In this clinical scenario, CMR may help to identify
AM as the underlying cause of clinical presentation
[52], although mild forms of inflammation may result in
a negative CMR examination [31].
CMR plays a role in the identification of other poten-
tial causes of previously undiagnosed ventricular arrhyth-
mias, such as arrhythmogenic right ventricular dysplasia,
non-compaction disease, atypical forms of hypertrophic
cardiomyopathy, and unknown chronic myocardial scars
[52]. CMR can also detect unexpected causes of acute
myocardial injury such as an unrecognized myocardial
infarction. Moreover, CMR results may provide impor-
tant prognostic information that should be considered in
patient management.
Indication of EMB is not well established in these pa-
tients: EMB should be considered only in exceptional
cases of unexplained ventricular arrhythmias [51], but it
is generally recommended when clinical and imaging
evaluation provides significant evidence of AM [49].
New insights and future developments: myocardial
mapping
The major limitations of current LLc are the qualitative (LGE
depiction) or semiquantitative (T2 ratio and EGEr) nature of
the diagnostic criteria, which significantly affects the sensitiv-
ity of the CMR technique in the characterization of global
myocardial processes.
To overcome many of these limitations, current research
has developed absolute quantitative approaches such as T1
and T2 mapping techniques.
Native T1 mapping
Measurement of native myocardial longitudinal relaxation
time (T1 mapping) has emerged as a novel quantitative ap-
proach to enable the depiction of diffuse inflammatory pro-
cesses. It is based on the generation of parametric maps
representing the T1 relaxation times encoded in each pixel of
any region of the heart, without the need to normalize mea-
surements to a reference standard tissue [14, 53, 54].
The basic principle of this technique relies on the concept
that pixel signal intensity depends on the relaxation of
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hydrogen nuclei protons in a static magnetic field, which
varies in the presence of oedema, fat infiltration, and fibrosis
[21].
Specifically, the prolongation of T1 relaxation time in AM
is related to an increase in both total and relative water content
in the intra- and extracellular space due to tissue oedema and
expansion of intercellular space [55]. A second phenomenon,
further enhancing T1 prolongation, is the altered electrolyte
distribution in the inflamed myocardial tissue, affecting the
motion of protons [56]. An initial experience published by
Ferreira et al. showed excellent diagnostic performance of
native T1 mapping in the clinical setting of AM, with around
90 % overall sensitivity, specificity, and diagnostic accuracy
[57].
More recently, Luetkens et al. convincingly demonstrated
the importance of a CMR multiparametric approach [21].
Native myocardial T1 mapping proved to be superior to the
EGEr technique and, alone, provided sensitivity comparable
to that obtained with the established LLc (92 vs. 92%, respec-
tively) [19, 21]. Hinojar et al. also reported the applicability of
a new diagnostic algorithm using native T1 for differentiating
acute from convalescent myocarditis (native T1 values: 940
vs. 1064 vs. 995 ms at 1.5 T and 1045 vs. 1189 vs. 1099 ms at
3 T in controls, acute myocarditis, and convalescent myocar-
ditis, respectively) [35].
Notably, a marked variation in diagnostic thresholds
among normal subjects has been reported in the literature
[58]. This variation in normal values of myocardial T1 is a
reflection of its direct dependence on magnetic field strength,
different physiologic parameters (mainly age, gender, and
heart rate), scanning parameters (mainly flip angle, matrix,
and slice thickness), and image analysis methods. One of the
major risks is the partial volume effect arising from over-
inclusion of neighbouring tissue [59]. Hence, in agreement
with current consensus statement [53], the validation of the
imaging protocol in each site using a reference sample of
Bnormal subjects^ is highly recommended in order to mini-
mize measurement errors. A more robust application of this
approach would certainly require greater standardization and
larger validation studies, which are currently lacking in the
literature.
Pre- and post-contrast T1 mapping with extracellular
volume fraction
Extracellular volume fraction (ECV) provides a direct mea-
surement of the size of the extracellular space. ECV map gen-
eration is based on a pixel-wise co-registration and compari-
son of native and post-contrast T1 maps, adjusted for the pa-
tient’s hematocrit [53]. In AM, an increase in ECV reflects
myocardial oedema and inflammation as well as myocyte ne-
crosis and subsequent myocardial fibrosis [21, 34, 60, 61]. In
recent studies, ECV alone achieved diagnostic accuracy of
approximately 75 % [21, 34, 36], which can improve to
90 % if ECV≥27 % is combined with the presence of LGE
in a stepwise diagnostic approach [34].
T2 mapping
An increased signal in T2-weighted images, which is linked to
T2 relaxation time (T2-rt) lengthening, is a well-known MR
sign of cardiac and skeletal muscle damage, reflecting hetero-
geneous phenomena such as oedema and inflammation.
Qualitative assessment of T2-weighted imaging is limited by
signal intensity heterogeneities and by the absence of the
Bperfect^ reference tissue for signal normalization. Direct
measurement of T2-rt accurately reflects inflammation in the
skeletal muscles [62] and also allows non-invasive monitoring
of inflammatory infiltration in the same setting [63]. Hence,
T2 mapping also holds promise as an attractive alternative for
the assessment of myocardial inflammation, particularly in the
case of diffuse oedema rather than focal involvement.
A T2-prepared steady-state free precession (T2p-SSFP)
technique has been described as a means of minimizing the
problems associated with current cardiac T2W imaging
methods, and of providing an accurate assessment of myocar-
dial oedema [64]. This T2p-SSFP approach allows the gener-
ation of three T2w images, each with different T2 preparation
times, in a single breath-hold (seven R–R intervals required).
Images obtained with this technique are less sensitive than
those of classical T2w-STIR to motion artefacts induced by
arrhythmias or imperfect breath-hold, and can be processed to
fit the T2 decay curve at each pixel to yield a T2 map. These
T2 maps also solve the critical problem of signal heterogene-
ity linked to the use of multi-element surface coils that typi-
cally affects STIR images. Results of T2mapping have shown
promise in the detection of myocardial involvement in acute
inflammatory cardiomyopathy, in particular in patients with
myocarditis and takotsubo cardiomyopathy, where T2 map-
ping allows the delineation of a greater extent of myocardial
involvement than wall motion abnormalities, T2w-STIR, or
LGE [65]. However, no other studies have confirmed the val-
ue of myocardial T2 mapping in AM, and thus further evi-
dence from multicenter trials is needed to prove its reproduc-
ibility and to assess its potential clinical role in patients with
suspected AM.
Conclusions
Since the publication of the JACC White Paper entitled
BCardiovascular Magnetic Resonance in Myocarditis^ in
2009, the relevance of CMR as a component of the clinical
workup in AM has increased dramatically. Several years of
application of LLc have allowed for a better understanding of
their value and limits, revealing flaws in providing wishful
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diagnostic results in some clinical situations. The EGE seems
to be the weakest point of LLc, both with respect to the pres-
ence of ambiguity and, more importantly, with the strong ar-
tefacts that very frequently affect this technique. T2w-STIR
sequences, although potentially affected by artefacts in some
patients and limited in the assessment of mild and diffuse
forms of myocardial involvement, may provide an intuitive
and rapid means of ascertaining active inflammation in focal
forms of disease. LGE is primarily affected by low sensitivity,
but has significant value in differential diagnosis and prognos-
tic evaluation. New perspectives in the diagnostic potential of
CMR were highlighted by the recent introduction of mapping
sequences, which provide insight into quantitative assessment
of inflammatory myocardial changes. New scientific evidence
supports the value and robustness of T1 mapping techniques
in the diagnosis of AM, with the chief advantage of increasing
CMR sensitivity. However, larger multicenter trials are needed
to develop a standardized T1/T2 mapping technique and to
define widely accepted normal thresholds values. On the other
hand, a step-by-step simple CMR protocol including T2w-
STIR, T1 mapping, and LGE (Fig. 4) could be hypothesized
and tested experimentally and in clinical practice.
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